Bibi, R., Bankole, N. D. A., Donnard, B., Giubbolini, F., Boucherit, J., Barrot, V., Herbreteau, D., Ifergan, H., Janot, K., Boulouis, G., & Bala, F.
Safety and Efficacy of Surpass Evolve Flow Diverter for Intracranial Aneurysms: A Study of 116 Patients
80.4%
Neck remnant or complete occlusion (OKM C-D) rate at 6 months
75.6%
Complete occlusion (OKM D) rate at 3 months
| Number of patients | 116 |
| Number of aneurysms | 120 |
| Major morbidity and mortality | 0.8% (1/107) |
| In-stent stenosis (25-49%) | 1.9% (2/107) |
| In-stent stenosis (≥50%) | 0.9% (1/107) |
Neuroradiology Journal | 2024
Bibi R, Bankole NDA, Donnard B, et al. Safety and efficacy of Surpass Evolve Flow diverter for intracranial aneurysms: A study of 116 patients. Neuroradiol J. 2024;37(2):184-191. doi:10.1177/19714009231224408
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004692 v1.0